Search Results - Joseph Wu

Joseph Wu

Official portrait, 2024 Wu Jaushieh (; born October 31, 1954), also known by his English name Joseph Wu, is a Taiwanese political scientist and diplomat currently serving as secretary-general of the National Security Council since 2024. He was formerly the foreign minister from 2018 to 2024 and secretary-general to the presidential office of Tsai Ing-wen from 2017 to 2018.

After earning his doctorate from Ohio State University, Wu became a political science professor. From 2007 to 2008, he was Chief Representative of Taiwan to the United States as the head of the Taipei Economic and Cultural Representative Office in Washington, D.C., having been appointed to that position by President Chen Shui-bian to succeed his predecessor, David Lee, who was appointed Minister of Foreign Affairs. On February 26, 2018, he succeeded Lee in that role as well. Provided by Wikipedia
  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Derivation of a Comprehensive Biobank of Human iPSC Lines for Open-Access Distribution to Academic Researchers

    Derivation of a Comprehensive Biobank of Human iPSC Lines for Open-Access Distribution to Academic Researchers by Christopher Yan, Celine Lai, Sushma Shenoy, Rebecca Yu, Zachary Cook, Julio Guevara, Yan Zhuge, Joseph Wu, Paul Pang

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    ADMET-AI enables interpretable predictions of drug-induced cardiotoxicity

    ADMET-AI enables interpretable predictions of drug-induced cardiotoxicity by Kyle Swanson, Souhrid Mukherjee, Parker Walther, Celine Lai, Christopher Yan, Rabindra Shivnaraine, Jeremy Leitz, Paul Pang, James Zou, Joseph Wu

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond

    Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, ran... by Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu, Linda Chen, Elizabeth Kudlacz, Joseph Wu

    Published 2019-06-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: